NCT07111546 2026-03-11A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]Nanjing Leads Biolabs Co.,LtdPhase 2 Recruiting140 enrolled